← Leaderboards
Pablo Power
Ubatec S.A.
$510,063
Attributed
$510,063
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $128.3K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$510,063 · 1
By mechanism
R01$510,063 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alaska”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Jinsy Andrews · Columbia University Health Sciences$9,819,674
- Suma Babu · Massachusetts General Hospital$9,819,674
- Sabrina Paganoni · Massachusetts General Hospital$9,819,674
- Sebastian Tong · University Of Washington$4,323,238
Research focus
AlaskaEnzyme PathwayAlaskanAntibioticsAntimicrobial ResistanceAntarcticaBacteriaAntibiotic ResistanceBeta-LactamaseBeta-Lactam ResistanceBeta-LactamsBiochemicalAttentionCarbapenemaseCarbapenem ResistanceCarbapenemsClassificationClinicCloningCollectionCrystallizationEarly DiagnosisEnvironmentEnzymes
Grant awards (4)
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens$127,235
R01 · FY2025 · AI · contact PI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens$128,258
R01 · FY2024 · AI · contact PI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens$126,842
R01 · FY2023 · AI · contact PI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens$127,728
R01 · FY2022 · AI · contact PI